.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Accenture
Dow
Citi
Deloitte
McKinsey
Express Scripts
Moodys
UBS

Generated: July 23, 2017

DrugPatentWatch Database Preview

Patents Expiring in April 2027

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Avid Radiopharms Inc
AMYVID
florbetapir f-18
SOLUTION;INTRAVENOUS202008-003Apr 6, 2012RXYesYes8,506,929► SubscribeYY AMYVID IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE BETA-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT
Avid Radiopharms Inc
AMYVID
florbetapir f-18
SOLUTION;INTRAVENOUS202008-003Apr 6, 2012RXYesYes7,687,052► SubscribeYY
Avid Radiopharms Inc
AMYVID
florbetapir f-18
SOLUTION;INTRAVENOUS202008-002Apr 6, 2012RXYesYes8,506,929► SubscribeYY AMYVID IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE BETA-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT
Avid Radiopharms Inc
AMYVID
florbetapir f-18
SOLUTION;INTRAVENOUS202008-002Apr 6, 2012RXYesYes7,687,052► SubscribeYY
Avid Radiopharms Inc
AMYVID
florbetapir f-18
SOLUTION;INTRAVENOUS202008-001Apr 6, 2012DISCNNoNo8,506,929► SubscribeYY AMYVID IS A RADIOACTIVE DIAGNOSTIC AGENT FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING OF THE BRAIN TO ESTIMATE BETA-AMYLOID NEURITIC PLAQUE DENSITY IN ADULT PATIENTS WITH COGNITIVE IMPAIRMENT
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cipla
Argus Health
Federal Trade Commission
US Department of Justice
Moodys
Colorcon
Medtronic
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot